You took the TSK and got a number. Now what?
You filled out 17 questions about fear of movement, added up the numbers, and landed on a score that feels like a verdict. It isn’t. The Tampa Scale of Kinesiophobia (TSK) is a self-report questionnaire that measures fear of movement and fear of (re)injury — not tissue damage, not diagnosis, and not a prediction of your individual rehab outcome. What it can do is help you locate which kind of caution is driving your behavior, and that distinction changes what you should do next.
This article explains the scoring mechanics, what the psychometric literature actually supports, and how to pair your score with three behavioral probes you can run at home. Then it gives you a phase-based plan with explicit dosage for acting on a high score. The goal is not to relabel you as a “high kinesiophobia patient.” The goal is to help you make a better decision this week.
What the TSK measures — and what it doesn’t
The TSK was developed to quantify fear of movement/(re)injury in people with musculoskeletal pain. A 2023 systematic review of its psychometric properties in people with musculoskeletal pain notes that clinical guidelines now recommend clinicians identify the presence of kinesiophobia because it may contribute to persistent pain and disability (Dupuis et al., Clinical Journal of Pain, 2023). That “may contribute” is doing real work. It is not a causal claim, and it does not mean your pain is “in your head.”
What the TSK does not measure: the integrity of your rotator cuff, the stiffness of your post-surgical knee, the degree of your disc bulge, or your likelihood of returning to work by a specific date. No retrieved source supports using a TSK score to predict an individual’s rehab outcome. If someone tells you your score means you will heal slowly, ask them for the primary study that supports that claim for someone with your presentation. It likely does not exist.
Why the 17-item version is the one to use
Five versions of the TSK were identified in the 2023 systematic review: TSK-17, TSK-13, TSK-11, TSK-4, and TSK-TMD (for temporomandibular disorders). Most versions showed good to excellent test-retest reliability (ICC 0.77 to 0.99) and good internal consistency (Cronbach’s alpha 0.68 to 0.91), except the TSK-4, whose reliability has yet to be defined. The review encourages use of the TSK-13 and TSK-17 as valid, reliable, and responsive (Dupuis et al., 2023).
The TSK-17, TSK-13, and TSK-11 were highly responsive to change; responsiveness has yet to be defined for the TSK-4 and TSK-TMD. If you are self-directing your rehab and want a version with the strongest combination of reliability, validity, and responsiveness, the TSK-17 or TSK-13 is the sensible choice. The TSK-11 is shorter but had a higher minimal detectable change — meaning it is less precise at detecting real change — and its construct validity was inconsistent between studies.
Scoring mechanics you can do yourself
The TSK-17 uses a 4-point Likert scale for each item: 1 = strongly disagree, 2 = somewhat disagree, 3 = somewhat agree, 4 = strongly agree. Four items — items 4, 8, 12, and 16 — are reverse-scored. That means if you answered “1” on a reverse-scored item, you count it as “4” in the total. The total score ranges from 17 to 68, with higher scores indicating greater kinesiophobia (as described in the Brazilian validation study by Mendes et al., BMC Musculoskeletal Disorders, 2024, and in a secondary clinical guide).
A note on the item text: Obtain the questionnaire from the original source or a licensed clinical provider rather than relying on a reproduced list from a secondary website.
Here is the arithmetic in plain terms:
- Score each item 1–4 as written.
- For items 4, 8, 12, and 16, subtract the item score from 5 (so a 1 becomes 4, a 2 becomes 3, a 3 becomes 2, and a 4 becomes 1).
- Add all 17 adjusted scores. The minimum is 17; the maximum is 68.
If you are using the TSK-13, the scoring is similar but the item set differs. Follow the instructions that accompany the version you obtained.
The two-factor reading: activity avoidance vs. somatic focus
A single total score can hide which pattern is driving your caution. A secondary clinical guide describes the TSK-17 as comprising two sub-domains: Activity Avoidance (11 items) and Somatic Focus (6 items). Activity avoidance reflects beliefs that physical activity will lead to injury or increased pain. Somatic focus reflects concerns that pain signals something seriously wrong with your body.
That distinction matters because the same total score can call for opposite first moves. If your score is driven mainly by activity avoidance, the lever is graded exposure — carefully dosing the feared movement until your nervous system updates its prediction. If your score is driven mainly by somatic focus, the lever is sensation relabeling plus paced loading — pairing the physical sensation with a neutral, accurate label while you build load tolerance.
A caveat on the two-factor structure: Factor structure is population-dependent. In a study of 335 Brazilian patients with chronic neck pain, the original 17-item unidimensional TSK structure showed inadequate fit indices (chi-square/DF > 3, TLI and CFI < 0.90, RMSEA > 0.08), while a two-domain, nine-item structure with domains labeled “somatic focus” and “activity avoidance” showed adequate fit (Mendes et al., 2024). That does not mean the 17-item version is useless — it means sub-scale interpretation should be treated as provisional for any individual reader. Use the sub-scores as a hypothesis about your pattern, not a confirmed diagnosis.
What the numbers actually support
Two psychometric findings are worth carrying into your self-assessment:
Reliability is good. Across versions, test-retest ICC ranged from 0.77 to 0.99 and internal consistency from 0.68 to 0.91 (Dupuis et al., 2023). Your score is not random noise.
But small changes are noise. The minimal detectable change (MDC) for the TSK-17 was 11% to 13% of the total score; for the TSK-13 it was 8%; for the TSK-11 it was 16% (Dupuis et al., 2023). If you scored 48 on the TSK-17, a drop to 45 over ten days is within measurement error. It is not evidence of progress, and it is not evidence of decline. Do not build a narrative around a three-point wobble.
This is why re-testing rules matter. Wait at least four weeks before interpreting change, and pre-commit to what change size you will treat as real. For a baseline of 48 on the TSK-17, an 11–13% change is roughly 5–6 points. Anything smaller is noise.
The “>37” convention: a conversation prompt, not a classifier
You will see the claim that a score above 37 indicates “high kinesiophobia” and predicts poorer health outcomes, attributed to Vlaeyen (1995). A secondary clinical guide states this cutoff and describes 17–37 as low to moderate. The primary source was not retrieved for this article, and the retrieved peer-reviewed literature does not establish >37 as a validated, universally applicable individual threshold.
Treat it as a conversation prompt inherited from a 1995 source, not a classifier. A reader should never let a single number relabel them as a “high kinesiophobia patient” without behavioral corroboration. The number is a starting coordinate. The behavior is the map.
Pair your score with three behavioral probes
Self-scoring is only useful if it changes a decision. Here is a decision rule: if your reported fear on a specific movement is high but your observed tolerance in a behavioral probe is adequate, the bottleneck is likely avoidance, and the prescription is exposure dosage. If your observed tolerance collapses alongside high somatic-focus items, the prescription is load reduction plus a clinical review — not more exposure.
Run these three probes on separate days, ideally within the same week you take the TSK. Record the numbers.
Probe 1: Timed sit-to-stand set
Use a standard chair with a firm seat. Sit with feet flat, arms crossed over your chest. Stand fully and sit back down at a controlled pace. Complete as many repetitions as you can in 30 seconds, or stop at 10 repetitions if you reach that first. Record the number of reps and your fear rating (0–10) before and after. This gives you an objective tolerance measure for a fundamental lower-body movement.
Probe 2: Loaded band row to a chosen effort level
Anchor a resistance band at chest height. Perform a seated or standing row with a load you can control for 8–12 repetitions at a perceived effort of 6–7 out of 10. Record the band tension (color or estimated pounds), the reps completed, and your fear rating before and after. This probes upper-body pulling tolerance under load.
Probe 3: Graded exposure to the specific movement you fear
Identify one movement you have been avoiding — a deep squat, an overhead reach, a single-leg balance, a stair descent. Perform it at a fear level of 3–4 out of 10. That means the movement should feel mildly uncomfortable but not threatening. Do 5–8 repetitions, 2–3 sets, and record your fear rating before, during, and after. If your fear rating spikes above 6, you have dosed too high; reduce the range, the load, or the speed.
Interpreting the discrepancy
Compare your TSK total and sub-scores with the probe results. If your TSK is high but your probe tolerance is adequate — you completed the sit-to-stand set without guarding, the row felt controlled, the feared movement was tolerable at a 3–4 fear level — your bottleneck is likely avoidance. The evidence from your own body contradicts the questionnaire’s prediction. That is useful information. It means the prescription is more exposure, not more protection.
If your TSK is high and your probe tolerance collapses — you cannot complete the sit-to-stand set without significant pain or guarding, the row reproduces your symptoms, the feared movement spikes your fear above 6 — the bottleneck may be somatic focus or an unresolved tissue issue. The prescription is load reduction, a clinical review, and a slower progression. Do not self-titrate exposure through a flare.
A phase-based plan for acting on a high score
The following protocol is an original synthesis of graded exposure and paced loading principles. It is not a research finding, and no retrieved source provides a specific effect size for TSK score reduction from this protocol. It is a practical structure for self-directed adults who want to convert a questionnaire score into a behavioral plan.
Phase 1 (weeks 1–2): Graded exposure at low fear
Frequency: Daily, or at least 5 days per week.
Dosage: 5–8 repetitions × 2–3 sets of the feared movement, performed at a fear level of 3–4 out of 10. Load via band or bodyweight scaled so the movement is completed without guarding. If you cannot complete the movement without bracing or holding your breath, reduce the range or the load until you can.
Progression criterion: Advance to Phase 2 when you can perform the movement at a fear level of ≤2 out of 10 for two consecutive sessions, with no increase in pain that lasts more than 24 hours.
Phase 2 (weeks 3–6): Progressive loading plus sensation relabeling
Frequency: 2–3 times per week for loading; one additional weekly session for somatic-focus work.
Dosage: 3 sets × 8–12 repetitions at a perceived effort of 6–7 out of 10. Increase load by a pre-set margin — for example, one band color or 5% of estimated load — when you complete all sets and reps with no more than a 2/10 fear rating and no flare lasting beyond 24 hours.
Somatic-focus session: Once weekly, perform the movement that generates the most somatic worry. As you perform it, pair the physical sensation with a neutral, accurate label: “This is a stretch sensation in the hamstring,” not “This is my disc tearing.” Do 3 sets × 8 repetitions at a fear level of 3–4. The goal is not to eliminate the sensation but to change the label attached to it.
Progression criterion: Advance to Phase 3 when you have increased load by at least one pre-set margin, your fear rating on the primary feared movement is ≤2 out of 10, and you have completed four weeks of consistent Phase 2 work.
Phase 3 (week 7 onward): Criteria-based progression and re-test
Frequency: 2–3 loading sessions per week, maintained indefinitely.
Dosage: Continue progressive loading at 3 sets × 8–12 repetitions, RPE 6–7, increasing load by a pre-set margin when the progression criteria are met.
Re-test: Retake the TSK-17 at week 4 and again at week 8. Do not interpret a change smaller than 11–13% of your baseline total as real. If your baseline was 48, a change to 43 or higher is within measurement error. A drop to 42 or below is a signal worth noting — but pair it with a behavioral change, not just a number change.
Advancement criterion: Advance when the feared movement is performed at ≤2/10 fear and load has increased by a pre-set margin. If either criterion is not met, repeat the current phase for another two weeks before re-testing.
When self-directed is the wrong setting
This protocol is designed for self-directed adults with a stable presentation. It is not appropriate for everyone. Route to a clinician rather than self-titrating if you experience:
- Escalating pain that does not settle within 24 hours of a session.
- New neurological signs — numbness, tingling, weakness, or loss of coordination that is new or worsening.
- A TSK score that is not budging alongside functional decline — you are doing the work, the score is not moving, and your ability to perform daily tasks is getting worse.
- Any symptom that feels systemically wrong — fever, unexplained weight loss, night pain that wakes you, or a history of cancer.
These are not reasons to catastrophize. They are reasons to get a clinical assessment before you continue. The TSK is a self-report measure, not a diagnostic tool, and it does not substitute for a physical examination when one is indicated.
FAQ
Can I use the TSK-11 instead of the TSK-17?
You can, but the TSK-11 had a higher minimal detectable change (16% of total score) and its construct validity was inconsistent between studies in the 2023 systematic review. The TSK-17 and TSK-13 are the versions the review encourages for validity, reliability, and responsiveness. If you want the most precise self-monitoring tool, use the TSK-17 or TSK-13.
My score went up after I started exercising. Does that mean I’m getting worse?
Not necessarily. A change smaller than 11–13% of your baseline total on the TSK-17 is within measurement error. If your score went from 40 to 43, that is noise. If it went from 40 to 50, that is a real change worth examining — but it still does not mean your tissue is worse. It may mean the exercise you chose was dosed too high, or that you are paying more attention to fear-related sensations because you are now doing more. Re-run the behavioral probes before you change your plan.
Does a high TSK score mean I should avoid exercise?
No. A high score means you have a strong fear-of-movement belief. The evidence-based response is graded exposure and paced loading, not avoidance. Avoidance reinforces the fear prediction. The protocol above is designed to dose exposure at a level your nervous system can tolerate — 3–4 out of 10 fear — so you can update the prediction without flooding yourself.
Is the TSK free to use?
A secondary clinical guide states that the TSK-17 is free for academic and clinical use and requires no licensing fees, but this was not corroborated by a primary or licensing source in the retrieved literature. If you plan to use the TSK in a commercial context, verify the licensing terms with the rights holder directly. For personal self-assessment, obtain the questionnaire from a legitimate clinical or academic source.
How often should I retake the TSK?
No more often than every four weeks. The minimal detectable change for the TSK-17 is 11–13% of the total score, which means short-interval changes are dominated by measurement error. Retaking the test weekly will give you noise, not signal, and may lead you to change your plan for the wrong reason.
The bottom line
Your TSK score is a coordinate, not a verdict. Use it to locate which pattern — activity avoidance or somatic focus — is driving your caution, pair it with behavioral probes that tell you what your body can actually tolerate, and dose your exposure accordingly. Re-test at four weeks, interpret change against the minimal detectable change, and route to a clinician if the score is not moving alongside functional decline. The number is useful. The behavior is what changes.